Sponsor:
Johns Hopkins University
Code:
NCT05282550
Conditions
AMCI - Amnestic Mild Cognitive Impairment
Sleep Disturbance
Eligibility Criteria
Sex: All
Age: 55+
Healthy Volunteers: Not accepted
Interventions
Trazodone
Placebo
Brief summary:
Conditions
AMCI - Amnestic Mild Cognitive Impairment
Sleep Disturbance
Study ID
NCT05282550
Start date
Feb 2, 2023
Status verified date
Jun, 2026
Completion date
Jun 30, 2028
Anticipated
Primary completion date
Jul 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 55+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
active comparator: Trazodone First
placebo comparator: Placebo First
Interventions
Trazodone
Placebo
Primary outcome measure
Central contacts
Locations
Johns Hopkins Hospital
Recruiting
Baltimore, Maryland, United States, 21205
Contacts
Principal Investigator:
Barry Greenberg, PhD
Sponsor
Johns Hopkins University
Last update posted
Jun 17, 2026
Last verified
Jun, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Johns Hopkins University on 2026-06-17.